Dr George Grigoriadis is a consultant haematologist at Bass Coast, Monash and Alfred Health; Senior Lecturer in The School of Clinical Sciences at Monash Health, Monash University, and Head of the Immunohaematology Research Group in Hudson Institute’s Centre for Cancer Research.

His research interests include

  • NF-κB in haematological malignancies
  • Inflammation in the evolution of myelodysplastic syndrome

Selected publications

  • Banerjee A, Mifsud N, Bird R, Forsyth C, Szer J, Tam C, Kellner S, Grigg A, Motum P, Bentley M, Opat S, Grigoriadis G (2015) The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: Implications for myelodysplasia and aplastic anaemia. Br J Haematol 168:576-82.

  • de Valle E, Grigoriadis G, O’Reilly L, Willis S, Lin A, Maxwell M, Corcoran L, Tsantikos E, Kirsten Fairfax K, Hibbs B, Vasanthakumar A, Febbraio M, Hibbs M, Pellegrini M, Banerjee A, Kallies A, MacKay F, Strasser A, Gerondakis S, Gugasyan R (2016) NFκB1 prevents the development of multi-organ autoimmunity by controlling IL-6 production in Follicular B cells. J Exp Med 213:621-41.

  • Talaulikar D, Tam CS, Joshua D, Ho JP, Szer J, Quach H, Spencer A, Harrison S, Mollee P, Roberts AW, Horvath N, Lee C, Zannettino A, Brown R, Augustson B, Jaksic W, Gibson J, Kalff A, Johnston A, Trotman J, Kalro A, Grigoriadis G, Ward C, Prince HM (2017) Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Intern Med J 47:35-49.